DD239207A5 - Verfahren zur herstellung von therapeutischen akzeptierbaren metallkomplexen der bis-indolverbindungen - Google Patents

Verfahren zur herstellung von therapeutischen akzeptierbaren metallkomplexen der bis-indolverbindungen Download PDF

Info

Publication number
DD239207A5
DD239207A5 DD85281749A DD28174985A DD239207A5 DD 239207 A5 DD239207 A5 DD 239207A5 DD 85281749 A DD85281749 A DD 85281749A DD 28174985 A DD28174985 A DD 28174985A DD 239207 A5 DD239207 A5 DD 239207A5
Authority
DD
German Democratic Republic
Prior art keywords
bis
group
metal
indole
zinc
Prior art date
Application number
DD85281749A
Other languages
German (de)
English (en)
Inventor
Takacsi Nagy
Gabor Szepesi
Maria Gazdag
Zsofia Pap
Kalman Burger
Original Assignee
�������@������@����������@����@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������@����������@����@��Kk�� filed Critical �������@������@����������@����@��Kk��
Publication of DD239207A5 publication Critical patent/DD239207A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
DD85281749A 1984-10-16 1985-10-15 Verfahren zur herstellung von therapeutischen akzeptierbaren metallkomplexen der bis-indolverbindungen DD239207A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU843861A HU195513B (en) 1984-10-16 1984-10-16 Process for producing stable solutions of alkaloides with bis-indole skeleton

Publications (1)

Publication Number Publication Date
DD239207A5 true DD239207A5 (de) 1986-09-17

Family

ID=10965811

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85281749A DD239207A5 (de) 1984-10-16 1985-10-15 Verfahren zur herstellung von therapeutischen akzeptierbaren metallkomplexen der bis-indolverbindungen

Country Status (29)

Country Link
US (1) US4684638A (sv)
JP (1) JPS61106584A (sv)
CN (1) CN1007958B (sv)
AT (1) AT389996B (sv)
AU (1) AU580342B2 (sv)
BE (1) BE903447A (sv)
CA (1) CA1272192A (sv)
CH (1) CH667459A5 (sv)
CS (1) CS251798B2 (sv)
DD (1) DD239207A5 (sv)
DE (1) DE3536745A1 (sv)
DK (1) DK169972B1 (sv)
ES (1) ES8701185A1 (sv)
FI (1) FI84134C (sv)
FR (1) FR2571724B1 (sv)
GB (1) GB2165540B (sv)
GR (1) GR852510B (sv)
HU (1) HU195513B (sv)
IE (1) IE58467B1 (sv)
IL (1) IL76719A (sv)
IN (1) IN162910B (sv)
IT (1) IT1186776B (sv)
LT (1) LT2203B (sv)
LU (1) LU86115A1 (sv)
LV (1) LV5175A3 (sv)
NL (1) NL192779C (sv)
SE (1) SE466017B (sv)
SU (1) SU1706372A3 (sv)
ZA (1) ZA857905B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341262C (en) * 1987-08-06 2001-06-26 Camille A. Boulet A new process of the synthesis of 3',4'-anhydrovinblastine, vinblastine and vincristine
US5170515A (en) * 1987-09-16 1992-12-15 Toto Ltd. Water closet
FR2623089B1 (fr) * 1987-11-13 1990-04-27 Pf Medicament Composition pharmaceutique pour l'administration parenterale de navelbine
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
US8017368B2 (en) * 2005-10-20 2011-09-13 University Of South Florida Molecular delivery to cells using aspirin-related compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE595570C (de) * 1932-10-07 1934-04-16 I G Farbenindustrie Akt Ges Verfahren zur Darstellung waesseriger Loesungen von Schwermetallverbindungen der aromatischen Halogenylsulfamide
US3426024A (en) * 1967-11-17 1969-02-04 Vanderbilt Co R T Amine complexes of zinc salts of chlorinated thiobisphenols
DE2502932C2 (de) * 1975-01-24 1985-04-18 Bayer Ag, 5090 Leverkusen Metallkomplexe von N-Trityl-azolen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide
FR2349335A1 (fr) * 1976-04-28 1977-11-25 Inst Int Pathologie Cellulaire Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
EP0071357B1 (en) * 1981-07-14 1985-01-02 Efamol Limited Pharmaceutical and dietary composition when used for enhancement of 1-series pg production
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi

Also Published As

Publication number Publication date
IT1186776B (it) 1987-12-16
DK472085A (da) 1986-04-17
ZA857905B (en) 1986-06-25
FI84134B (fi) 1991-07-15
IE58467B1 (en) 1993-09-22
DK169972B1 (da) 1995-04-18
DE3536745A1 (de) 1986-04-17
CN85107053A (zh) 1986-06-10
IE852531L (en) 1986-04-16
CS251798B2 (en) 1987-08-13
GR852510B (sv) 1986-02-18
DK472085D0 (da) 1985-10-15
AU580342B2 (en) 1989-01-12
AT389996B (de) 1990-02-26
NL192779B (nl) 1997-10-01
IN162910B (sv) 1988-07-23
FI853123L (fi) 1986-04-17
LT2203B (lt) 1993-10-15
LV5175A3 (lv) 1993-10-10
GB8525360D0 (en) 1985-11-20
CH667459A5 (de) 1988-10-14
NL8502821A (nl) 1986-05-16
SE8504786L (sv) 1986-04-17
IL76719A (en) 1989-10-31
GB2165540B (en) 1988-04-27
FI84134C (sv) 1991-10-25
IT8522482A0 (it) 1985-10-15
AU4871485A (en) 1986-04-24
JPH0339489B2 (sv) 1991-06-14
FR2571724A1 (fr) 1986-04-18
ES8701185A1 (es) 1986-11-16
GB2165540A (en) 1986-04-16
JPS61106584A (ja) 1986-05-24
ES547862A0 (es) 1986-11-16
FI853123A0 (fi) 1985-08-15
FR2571724B1 (fr) 1988-08-26
SU1706372A3 (ru) 1992-01-15
ATA297985A (de) 1989-08-15
NL192779C (nl) 1998-02-03
BE903447A (fr) 1986-04-15
SE8504786D0 (sv) 1985-10-15
CN1007958B (zh) 1990-05-16
IL76719A0 (en) 1986-02-28
HU195513B (en) 1988-05-30
LU86115A1 (de) 1986-03-24
DE3536745C2 (sv) 1992-01-23
US4684638A (en) 1987-08-04
CA1272192A (en) 1990-07-31
SE466017B (sv) 1991-12-02

Similar Documents

Publication Publication Date Title
DE69402022T2 (de) Stabilisierte Arzneimittel und stabilisierendes Lösungsmittel
DE1417343A1 (de) Verfahren zur Herstellung einer antibiotechnischen Zusammensetzung
DE69708121T3 (de) Halogenid-enthaltende insulinzubereitungen
DE3837825A1 (de) Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DE3536745C2 (sv)
DE2731648A1 (de) Sulfadiazinsalze von seltenen erdmetallen und thorium, insbesondere cersulfadiazin, verfahren zu ihrer herstellung und ihre verwendung zur lokalen behandlung von verbrennungen
DE3715918C2 (sv)
DD157535A5 (de) Verfahren zur herstellung einer fluessigen,stabilisierten isotonischen zubereitung
AT401469B (de) Pharmazeutische wässrige lösung zur parenteralen anwendung enthaltend einen in situ gebildeten komplex von einem alkaloid mit bis-indol-gerüst, sowie verfahren zu deren herstellung
DE2743586A1 (de) Injizierbare loesung und verfahren zur herstellung derselben
DE3112272A1 (de) Pharmazeutisches mittel
DE1231847B (de) Verfahren zur Herstellung von parenteral applizierbaren waessrigen Loesungen von substituierten Benzochinonen
DE1467749A1 (de) Verfahren zur Herstellung von stabilen Tetracyclinpraeparaten
CH636766A5 (de) Infusionsloesung zur behandlung von hepatischer encephalopathie und ein verfahren zu deren herstellung.
DE977478C (de) Verfahren zur Herstellung injizierbarer Insulinpraeparate mit verzoegerter Wirkung
DE68902755T2 (de) Antineoplastische formulierungen.
DE1792448C3 (de) Verfahren zur Herstellung von zur parenteralen Verabreichung geeigneten stabilen Lösungen von therapeutisch anwendbaren Benzodiazepinderivaten
CA1296253C (en) Stabilized growth hormone compositions
DE2445270C2 (de) Stabilisierte wäßrige Adrenalin-Augenlösung
AT344328B (de) Verfahren zur herstellung einer stabilisierten waesserigen loesung zur topischen anwendung auflebendes gewebe mit einem gehalt an brenzcatechinaminderivaten
DE934664C (de) Verfahren zur Herstellung von Proteohormonverbindungen
DE901695C (de) Verfahren zur Herstellung haltbarer, gerbend wirkender Loesungen
DE2556001B2 (de) Spritzfertige injizierbare Lösungen mit einem Gehalt an Alkalicanrenoat
DE1155880B (de) Verfahren zur Herstellung von konzentrierten, waessrigen Orotsaeure-Loesungen
DE1417343C (de) Flüssige stabile Arzneimittel auf der Basis von Magnesiumkomplexsalzen des Oxytetracycline. Arun: Chas. Pfizer & Co Inc., Brooklyn, N.Y. (V.St.A.); Ttr: Beil, Dr. W.; Hoeppener, A.; Rechtsanwälte, 6230 Frankfurt-Höchst

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee